The new pyridinediphosphinite ligand PONOP (1) was synthesized in one step from 2,6-pyridinedimethanol and diphenylchlorophosphane. Reaction of 1 with PtCl(2)(PhCN)(2) led to the neutral homobimetallic complex [Pt(2)Cl(4)(PONOP)(2)] (2), where the benzonitriles have been substituted by the phosphorus atoms of 1. The X-ray structure of 2 revealed a metallamacrocycle where the pyridines remained free. Addition of 2 equiv of [Cu(MeCN)(4)](BF(4)) to 2 led to CuCl and to the binuclear dicationic complex [Pt(2)Cl(2)(PONOP)(2)](BF(4))(2) (3), where chloro ligands have been substituted by pyridine groups. Conversely, reaction of 3 with chloride anions gave back complex 2. Solid-state (X-ray) and solution (NMR) studies indicated that after the transformation of 2 into 3, the platinum centers were brought much closer and the pyridinediphosphinite ligand was stiffened. The methylene NMR protons of 3 were strongly deshielded, and the corresponding proton-phosphorus coupling constants followed a Karplus-type relationship.
The chiral diphospholane ligands Duphos (1) and Duxantphos (2), which can be differentiated by their bite angle, were applied to palladium-catalysed asymmetric reactions, essentially allylic alkylations with symmetrically (3a−d) or unsymmetrically (5a,b) substituted allylic acetates as substrates. The most interesting results were found with the first series of substrates in which 2 was more reactive and/or selective than 1. The model complexes of the catalytic intermediates [Pd{(S,S)-1}(η 3 -cyclohexenyl)](BF 4 ) (10) and exo-[Pd{(R,R)-2}(η 3 -cyclohexenyl)](SbF 6 ) (11) could be characterised by X-ray crystallography.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.